turing pharmaceuticals

The 31-track double album was announced in 2014.
But don't worry, poor people, hospitals will get a price cut.
Since investors led by Martin Shkreli swooped in, the price of KaloBios has skyrocketed.
She said CEO Martin Shkreli should "do the right thing."
CEO Martin Shkreli didn't say how much he'd cut the cost of Daraprim.
Martin Shkreli is part of a federal probe involving a biotech company that fired him last year.